Imenez Silva Pedro Henrique, Wesson Donald E, Wagner Carsten A
Institute of Physiology, University of Zurich, Zurich, Switzerland.
Dell Medical School - The University of Texas at Austin, Austin, U.S.A.
Biochem Soc Trans. 2023 Feb 27;51(1):223-232. doi: 10.1042/BST20220690.
Chronic kidney disease (CKD) is characterized by progressive reduction in kidney function and treatments aiming at stabilizing or slowing its progression may avoid or delay the necessity of kidney replacement therapy and the increased mortality associated with reduced kidney function. Metabolic acidosis, and less severe stages of the acid stress continuum, are common consequences of CKD and some interventional studies support that its correction slows the progression to end-stage kidney disease. This correction can be achieved with mineral alkali in the form of bicarbonate or citrate salts, ingestion of diets with fewer acid-producing food components or more base-producing food components, or a pharmacological approach. In this mini-review article, we summarize the potential mechanisms involved in the beneficial effects of alkali therapy. We also discuss the perspectives in the field and challenges that must be overcome to advance our understanding of such mechanisms.
慢性肾脏病(CKD)的特征是肾功能进行性减退,旨在稳定或减缓其进展的治疗可能避免或推迟肾脏替代治疗的必要性以及与肾功能减退相关的死亡率增加。代谢性酸中毒以及酸应激连续体中不太严重的阶段是CKD的常见后果,一些干预性研究支持纠正代谢性酸中毒可减缓向终末期肾病的进展。这种纠正可以通过碳酸氢盐或柠檬酸盐形式的矿物碱、摄入产酸食物成分较少或产碱食物成分较多的饮食或药物方法来实现。在这篇小型综述文章中,我们总结了碱疗法有益作用所涉及的潜在机制。我们还讨论了该领域的前景以及为推进我们对这些机制的理解必须克服的挑战。